the bioregulator company - follow up results after ......peptide bioregulator europe ab follow up...
TRANSCRIPT
![Page 1: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/1.jpg)
Peptide Bioregulator Europe ABwww.peptide-bioregulator.com
FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH
GENETIC RETINAL DISORDERS
![Page 2: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/2.jpg)
Few words about Retinitis Pigmentosa
•A group of genetic disorders•Affect the retina’s ability to respond to light•Symptoms:-Decreased night vision- night blindness (nyktalopia)-Loss of side (peripheral) vision- tubular vision-Blindness results.•There is no cure.
Normal eyeEye with RP
![Page 3: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/3.jpg)
Tubular vision
![Page 4: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/4.jpg)
![Page 5: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/5.jpg)
• Female patient • 39 years old• Pathology: Retinitis pigmentosa• Visual acuity before treatment: RE 5/10 cc LE 5/10 cc• First visit: February 2014
Case #1
![Page 6: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/6.jpg)
Case #1
Visual Fields Pre-Treatment
![Page 7: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/7.jpg)
Case #1
![Page 8: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/8.jpg)
Case #1
![Page 9: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/9.jpg)
Case #1
Results?
Improvement for the Right eye. Expansion of the central photosensitive area.Visual acuity before treatment: RE 5/10 ccVisual acuity after treatment : RE 5/10 cc
![Page 10: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/10.jpg)
Case #1
Results?
Stabilization for the Left eye.Visual acuity before treatment: LE 5/10 ccVisual acuity after treatment: LE 5/10 cc
![Page 11: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/11.jpg)
Case #2
• Male patient
• 17 years old
• Pathology: Retinitis pigmentosa
• Visual acuity before treatment:
RE: 6/10 cc
LE: 6/10 cc
• First visit: January 2014
![Page 12: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/12.jpg)
Case #2
Visual fields pre-treatment
![Page 13: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/13.jpg)
Case #2
Visual fields after 10 days
Visual acuity RE: 7/10 ccVisual acuity RE: 6/10 cc
![Page 14: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/14.jpg)
Case #2
Visual fields post treatment (35 days from the beginning)
Visual acuity RE: 7/10 ccVisual acuity RE: 7/10 cc
![Page 15: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/15.jpg)
Case #2
Visual acuity LE: 7/10 ccVisual acuity LE: 6/10 cc
Visual fields after 10 days
![Page 16: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/16.jpg)
Case #2
Visual acuity LE: 7/10 ccVisual acuity LE: 7/10 cc
Visual fields post-Treatment (35 days from the beginning)
![Page 17: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/17.jpg)
Case #2
• Visual acuity RE: 7/10 cc
LE: 7/10 cc
Patient received a second round of therapy in July 2014.
![Page 18: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/18.jpg)
Case #2
Visual acuity RE: 7/10 cc
![Page 19: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/19.jpg)
Case #2
Visual acuity LE: 7/10 cc
![Page 20: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/20.jpg)
Case #2
• Visual acuity RE: 7/10 cc
LE: 7/10 cc
Patient received a third round of therapy in February 2015
![Page 21: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/21.jpg)
Case #2
Visual acuity RE: 7/10 cc
![Page 22: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/22.jpg)
Visual acuity RE: 7/10 cc
![Page 23: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/23.jpg)
![Page 24: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/24.jpg)
Case #2
Results?
Improvement for the Right eye. Expansion of the central photosensitive area.Visual acuity before any treatment: 6/10 cc.Visual acuity after 2 rounds of treatment: 7/10cc.
![Page 25: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/25.jpg)
Case #2
Visual acuity LE: 7/10 cc
![Page 26: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/26.jpg)
Visual acuity LE: 7/10 cc
Case #2
![Page 27: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/27.jpg)
Case #2
![Page 28: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/28.jpg)
Case #2
Results?
Improvement for the left eye. Expansion of the central photosensitive area.Visual acuity before any treatment: 6/10 cc.Visual acuity after 2 rounds of treatment: 7/10 cc.
![Page 29: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/29.jpg)
• Female patient
• 64 years old
• Pathology: Retinitis pigmentosa
• Visual acuity before treatment:
RE blind
LE: 4/10 cc
• First visit: May 2014
Case #3
![Page 30: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/30.jpg)
Case #3
Pre-treatment Post treatment
![Page 31: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/31.jpg)
Case #3
Pre-treatmentVA 4/10 cc
Post treatmentVA 4-5/10 cc
Results? Stabilization. Expansion of the central photosensitive area.
![Page 32: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/32.jpg)
• Male patient
• 33 years old
• Pathology: Retinitis pigmentosa
• Visual acuity before treatment
RE: 7/10 cc
LE: 3/10 cc
• First visit: October 2013
Case #4
![Page 33: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/33.jpg)
Case #4
Visual fields pre treatment
![Page 34: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/34.jpg)
Visual fields after 10 days
Visual acuity RE: 8/10 cc
Case #4
Visual acuity RE: 7/10 cc
![Page 35: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/35.jpg)
Visual fields post treatment (20 days from the beginning)
Visual acuity RE: 8/10 cc
Case #4
Visual acuity LE: 7/10 cc
![Page 36: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/36.jpg)
Visual acuity LE: 3/10 cc
Case #4
Visual acuity LE: 3/10 cc
Visual Fields after 10 days
![Page 37: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/37.jpg)
Visual acuity LE: 5/10 cc
Case #4
Visual acuity LE: 3/10 cc
Visual Fileds post-Treatment (20 days from the beginning)
![Page 38: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/38.jpg)
Patient received a second round of therapy in February 2014.
Case #4
• Visual acuity RE: 8/10 cc
LE: 5/10 cc
![Page 39: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/39.jpg)
Case #4
Visual acuity RE: 9/10 ccVisual acuity RE: 8/10 cc
![Page 40: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/40.jpg)
Case #4
Visual acuity LE: 5/10 ccVisual acuity LE: 5/10 cc
![Page 41: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/41.jpg)
Case #4
• Visual acuity RE: 9/10 cc
LE: 5/10 cc
Patient received a third round of therapy in June 2014
![Page 42: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/42.jpg)
Case #4
Visual acuity RE: 9/10 cc
![Page 43: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/43.jpg)
Visual acuity RE: 9/10 ccCase #4
![Page 44: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/44.jpg)
Case #4
![Page 45: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/45.jpg)
Case #4
Visual acuity LE: 5/10 cc
![Page 46: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/46.jpg)
Case #4
![Page 47: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/47.jpg)
Case #4
![Page 48: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/48.jpg)
Case #4
Results?
Improvement for the right eye.Visual acuity before any treatment: 7/10 cc.Visual acuity after 2 rounds of treatment : 9/10 cc
![Page 49: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/49.jpg)
Case #4
Results?
Stabilization for the left eye.Visual acuity before any treatment: 3/10 ccVisual acuity after 2 rounds of treatment: 5/10 cc
![Page 50: The Bioregulator Company - FOLLOW UP RESULTS AFTER ......Peptide Bioregulator Europe AB FOLLOW UP RESULTS AFTER TREATMENT WITH PEPTIDE BIOREGULATORS IN PATIENTS WITH GENETIC RETINAL](https://reader036.vdocuments.site/reader036/viewer/2022071608/61462c178f9ff812542017cf/html5/thumbnails/50.jpg)
Peptide Bio Regulator Europe AB European Medical Center for
Peptide Bio Regulation
OFFICE: +46 760 655 769Mail to: medical.center@peptide-
bioregulator.com
www.peptide-bioregulator.com